United Biomedical, a Taiwan biopharmaceutical firm developing COVID-19 vaccines, on Thursday said it had initially planned on following international norm and entering phase 3 clinical trials before seeking government approval for its COVID-19 vaccine.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Taiwan's indigenous submarine undergoes final stage of harbor trials
06/15/2025 03:57 PM - Culture
It's a gourd life: Tamsui farmer reclaims 'heaviest pumpkin' title
06/15/2025 03:35 PM - Society
NGOs demand Taiwan provide insurance for domestic migrant workers
06/15/2025 02:54 PM - Society
Temperature in Taipei's Shilin District soars past 37°C on Sunday
06/15/2025 01:32 PM - Society
Taiwan headline news
06/15/2025 12:18 PM